Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

August 30, 2016August 30, 2016

Depression Lowest in Women with Systemic Sclerosis Who Are Happily Married, Study Says

News

A marriage or near-marriage relationship that is satisfying can considerably help to ease depression in women with systemic sclerosis compared to single woman with disease-related symptoms of depression, according to ... Read more

August 23, 2016August 23, 2016

Novel Scale for Scleroderma Patients Measures Social Avoidance Related to Body Image

News

People with clinical manifestations that affect appearance, such as those with systemic sclerosis (SSc), are more likely to exhibit social avoidance behaviors due to body image concerns. In a ... Read more

August 9, 2016August 24, 2016

Esbriet Seen as Safe for Systemic Sclerosis Patients with ILD, Further Studies Likely

News

Esbriet (pirfenidone) has an acceptable level of tolerability in patients with systemic sclerosis (SSc) associated with interstitial lung disease (ILD), and may be tested for efficacy in future clinical trials ... Read more

July 26, 2016July 26, 2016

Systemic Sclerosis Patient Reported for First Time with Both Watermelon Stomach and Colon, Researchers Say

News

Systemic sclerosis may lead to the appearance of gastrointestinal (GI) lesions that resemble the stripes of a watermelon, which explains the expression “watermelon stomach.” Although it is often restricted ... Read more

July 18, 2016August 18, 2016

Rituximab Trial for Systemic Sclerosis-associated PAH Enrolling Participants

News

The National Institute of Allergy and Infectious Diseases is recruiting patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) to assess if Rituxan (rituximab) immunotherapy is effective against disease progression. The randomized Phase ... Read more

July 12, 2016July 12, 2016

Scleroderma Patients with PAH Seen to Benefit from PDE-5 Inhibitors as Early Therapy

News

People with systemic sclerosis-associated pulmonary arterial hypertension (SS-PAH) were seen to have a significantly worse prognosis when treated with an endothelin receptor antagonist (ERA), compared to those treated with a phosphodiesterase-5 (PDE-5) ... Read more

July 7, 2016July 7, 2016

Implanted Heart Monitor in Systemic Sclerosis Patients Helps Detect Arrhythmias Early

News

Keeping close watch over systemic sclerosis patients, at high risk for cardiovascular disease, with an implanted heart monitoring device may allow for early detection and treatment of cardiac events. Researchers at the University of ... Read more

May 12, 2016May 13, 2016

Phase 2 Trial Suggests Tocilizumab May Be of Benefit to Systemic Sclerosis Patients

News

A Phase 2 clinical trial investigating the efficacy and safety of tocilizumab, an interleukin 6 receptor-α inhibitor, revealed a clinically significant — although not statistically significant — improvement of skin ... Read more